Table:
begin	end	state
1	8	cytoplasmic
9	27	transmembrane
28	32	non-cytoplasmic
33	52	transmembrane
53	61	cytoplasmic
62	81	transmembrane
82	107	non-cytoplasmic
108	136	transmembrane
137	143	cytoplasmic
144	162	transmembrane
163	181	non-cytoplasmic
182	206	transmembrane
207	229	cytoplasmic
230	249	transmembrane
250	268	non-cytoplasmic
269	289	transmembrane
290	306	cytoplasmic
307	326	transmembrane
327	347	non-cytoplasmic
348	380	transmembrane
381	389	cytoplasmic
390	413	transmembrane
414	427	non-cytoplasmic
428	449	transmembrane
450	450	cytoplasmic

Input:
>PP_3417
MFGLATDTFLLLDALVTIVGLILLITHFKVHPFVALTLAAGFLGLTSGMPVAKVMKSFQD
GFGGVLGFVGIVLALGTMLGKLMADSGGADQIAQTLIRAFGKKNVHWAMMFAAFLVGIPL
FFEIGFVLLIPLVFIVARRSGVSLVKIGIPLLAGLSVVHGLVPPHPGPLLAIGIFHADIG
KTIFYGLIVALPTAIIAGPLFGNFISRYIPGNPSQELMDQIAKDSDQGNLPSFSITLVTV
LLPVALMLLKTFADVVLPAEHIVRQWMDLIGHPITALLAALLLAFYTFGSARGFNRQQIM
KMLDQSLAPTAAIVLIVGAGGGFKQMLVDTGVGNVIGQMAVQAEISPIMLAWLVAAVIRI
ATGSATVATITGAGIVAPVIDLVPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT
VAETFKTWSMMETILSIVGIIFIMLLSLVV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server